GLP-1 receptor agonists affect metabolic, inflammatory, and neuronal survival pathways implicated in Parkinson’s disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results